» Articles » PMID: 34096310

Mechanistic Insight into How PEGylation Reduces the Efficacy of PH-Sensitive Liposomes from Molecular Dynamics Simulations

Overview
Journal Mol Pharm
Specialty Pharmacology
Date 2021 Jun 7
PMID 34096310
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Liposome-based drug delivery systems composed of DOPE stabilized with cholesteryl hemisuccinate (CHMS) have been proposed as a drug delivery mechanism with pH-triggered release as the anionic form (CHSa) is protonated (CHS) at reduced pH; PEGylation is known to decrease this pH sensitivity. In this manuscript, we set out to use molecular dynamics (MD) simulations with a model with all-atom resolution to provide insight into why incorporation of poly(ethyleneglycol) (PEG) into DOPE-CHMS liposomes reduces their pH sensitivity; we also address two additional questions: (1) How CHSa stabilizes DOPE bilayers into a lamellar conformation at a physiological pH of 7.4? and (2) how the change from CHSa to CHS at acidic pH triggers the destabilization of DOPE bilayers? We found that (A) CHSa stabilizes the DOPE lipid membrane by increasing the hydrophilicity of the bilayer surface, (B) when CHSa changes to CHS by pH reduction, DOPE bilayers are destabilized due to a reduction in bilayer hydrophilicity and a reduction in the area per lipid, and (C) PEG stabilizes DOPE bilayers into the lamellar phase, thus reducing the pH sensitivity of the liposomes by increasing the area per lipid through penetration into the bilayer, which is our main focus.

Citing Articles

Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery.

Paloncyova M, Valerio M, Dos Santos R, Kuhrova P, Srejber M, cechova P Mol Pharm. 2025; 22(3):1110-1141.

PMID: 39879096 PMC: 11881150. DOI: 10.1021/acs.molpharmaceut.4c00744.


When conventional approach in toxicity assays falls short for nanomedicines: a case study with nanoemulsions.

Nikolic I, dokovic J, Mehn D, Guerrini G, Savic S, Jordan O Drug Deliv Transl Res. 2025; .

PMID: 39779651 DOI: 10.1007/s13346-024-01776-7.


αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment.

Pandey P, Arya D, Deepak P, Ali D, Alarifi S, Srivastava S Bioengineering (Basel). 2024; 11(8).

PMID: 39199757 PMC: 11352135. DOI: 10.3390/bioengineering11080800.


Lipid-Coated Polymeric Nanoparticles for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinomas.

Roschenko V, Ayoub A, Engelhardt K, Schafer J, Amin M, Preis E Pharmaceutics. 2023; 15(10).

PMID: 37896172 PMC: 10610306. DOI: 10.3390/pharmaceutics15102412.


Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria.

Tian Y, Zheng Z, Wang X, Liu S, Gu L, Mu J J Nanobiotechnology. 2022; 20(1):318.

PMID: 35794597 PMC: 9258070. DOI: 10.1186/s12951-022-01493-8.


References
1.
Lai M, Vail W, Szoka F . Acid- and calcium-induced structural changes in phosphatidylethanolamine membranes stabilized by cholesteryl hemisuccinate. Biochemistry. 1985; 24(7):1654-61. DOI: 10.1021/bi00328a013. View

2.
Viricel W, Mbarek A, Leblond J . Switchable Lipids: Conformational Change for Fast pH-Triggered Cytoplasmic Delivery. Angew Chem Int Ed Engl. 2015; 54(43):12743-7. DOI: 10.1002/anie.201504661. View

3.
Ellens H, Bentz J, Szoka F . H+- and Ca2+-induced fusion and destabilization of liposomes. Biochemistry. 1985; 24(13):3099-106. DOI: 10.1021/bi00334a005. View

4.
Rog T, Pasenkiewicz-Gierula M, Vattulainen I, Karttunen M . Ordering effects of cholesterol and its analogues. Biochim Biophys Acta. 2008; 1788(1):97-121. DOI: 10.1016/j.bbamem.2008.08.022. View

5.
Cullis P, Hope M, Tilcock C . Lipid polymorphism and the roles of lipids in membranes. Chem Phys Lipids. 1986; 40(2-4):127-44. DOI: 10.1016/0009-3084(86)90067-8. View